Correlation Between Lexicon Pharmaceuticals and Sarepta Therapeutics

Can any of the company-specific risk be diversified away by investing in both Lexicon Pharmaceuticals and Sarepta Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Lexicon Pharmaceuticals and Sarepta Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Lexicon Pharmaceuticals and Sarepta Therapeutics, you can compare the effects of market volatilities on Lexicon Pharmaceuticals and Sarepta Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Lexicon Pharmaceuticals with a short position of Sarepta Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Lexicon Pharmaceuticals and Sarepta Therapeutics.

Diversification Opportunities for Lexicon Pharmaceuticals and Sarepta Therapeutics

0.23

Correlation Coefficient

Lexicon Pharmaceuticals  Sarepta Therapeutics

Modest diversification

The 3 months correlation between Lexicon and Sarepta is 0.23. Overlapping area represents the amount of risk that can be diversified away by holding Lexicon Pharmaceuticals and Sarepta Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sarepta Therapeutics and Lexicon Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Lexicon Pharmaceuticals are associated (or correlated) with Sarepta Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sarepta Therapeutics has no effect on the direction of Lexicon Pharmaceuticals i.e., Lexicon Pharmaceuticals and Sarepta Therapeutics go up and down completely randomly.

Pair Corralation between Lexicon Pharmaceuticals and Sarepta Therapeutics

Given the investment horizon of 90 days Lexicon Pharmaceuticals is expected to generate 5.23 times more return on investment than Sarepta Therapeutics. However, Lexicon Pharmaceuticals is 5.23 times more volatile than Sarepta Therapeutics. It trades about 0.11 of its potential returns per unit of risk. Sarepta Therapeutics is currently generating about -0.06 per unit of risk. If you would invest  69.00  in Lexicon Pharmaceuticals on October 5, 2024 and sell it today you would earn a total of  9.00  from holding Lexicon Pharmaceuticals or generate 13.04% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Lexicon Pharmaceuticals  vs.  Sarepta Therapeutics

Lexicon Pharmaceuticals

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Lexicon Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in February 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Sarepta Therapeutics

Risk-Adjusted Performance

3 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Sarepta Therapeutics are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak basic indicators, Sarepta Therapeutics may actually be approaching a critical reversion point that can send shares even higher in February 2025.

Pair Trading with Lexicon Pharmaceuticals and Sarepta Therapeutics

The main advantage of trading using opposite Lexicon Pharmaceuticals and Sarepta Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Lexicon Pharmaceuticals position performs unexpectedly, Sarepta Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sarepta Therapeutics will offset losses from the drop in Sarepta Therapeutics' long position.

The idea behind Lexicon Pharmaceuticals and Sarepta Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.